VARICELLA-ZOSTER-COMPLE FIX ANTIGEN AND NEG CONTRO— 510(k) K852930

Name: FDA 510(k) clearance K852930
Creator: U.S. Food and Drug Administration
Published: 1985-11-12

Substantially Equivalent

Microbix Biosystems, Inc.

FDA 510(k) clearance K852930 for VARICELLA-ZOSTER-COMPLE FIX ANTIGEN AND NEG CONTRO, Substantially Equivalent on 1985-11-12. Applicant: Microbix Biosystems, Inc.. Device class: 2.

Clearance details

Applicant: Microbix Biosystems, Inc.
Product code: Code GQX
Device class: Class 2
Regulation: 21 CFR 866.3900
Advisory panel: Microbiology
Date received: 1985-07-09
Decision date: 1985-11-12
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Canada, CA

Download summary PDF View on FDA.gov ↗

Recent devices under product code GQX

view all

K951799 — VARICELLA-ZOSTER VIRUS DIRECT IMMUNOFLUORESCENCE ASSAY1996-03-20
K911301 — VZV IGM TEST1991-07-17
K883427 — VIRGO(R) VZV-IGG ELISA1989-03-10
K875358 — VZV TEST1988-03-31
K863317 — ENZYGNOST ANTI-VZV IGG TEST1987-04-22

More clearances from Microbix Biosystems, Inc.

view all

K894261 — TOXOPLASMA GONDII-CF ANTIGEN AND CONTROL ANTIGEN1989-10-16
K894262 — RUBELLA ANTIGEN AND CONTROL ANTIGEN1989-10-16
K852929 — CMV-COMPLEMENT FIXATION ANTIGEN AND NEGATIVE CONTR1985-11-12
K852931 — HERPES HOMINUS I-COMPLE FIX ANTIGEN & NEGATIVE CLT1985-11-12
K852932 — MEASLES-COMPLEMENT FIX ANTIGEN & NEGATIVE CLT1985-11-12

Data sourced from openFDA. This site is unofficial and independent of the FDA.